Terremoto Biosciences

📍 San Francisco, United States👥 42 employees💰 Last funded Oct 2023
Biotechnology Research🌐 terremotobio.com
Website LinkedIn
Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy. The company leverages the power of lysine-based covalency across the disease spectrum to develop both best-in-class therapies against known drug targets and first-in-class medicines against the previously undruggable. Many of Terremoto’s founders helped establish this emergent area of science, with the intent to broaden the number of tractable targets and deliver medicines with superior therapeutic benefit. Terremoto is supported by leading investors OrbiMed and Third Rock Ventures. More information is available at www.terremotobio.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Terremoto Biosciences?
Terremoto Biosciences has 1 investors on record on gritt.io.
When did Terremoto Biosciences last raise funding?
The most recent investment in Terremoto Biosciences recorded on gritt.io was in October 2023.
What industry is Terremoto Biosciences in?
Terremoto Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Terremoto Biosciences based?
Terremoto Biosciences is headquartered in San Francisco, United States.